ZyCoV-D: World's First Needle-Free DNA Vaccine’s Emergency Approval in India

Abstract

The world's first DNA-based Coronavirus vaccine has received emergency permission from India's medicines authority. Zydus Cadila, a pharmaceutical firm, created the three-dose, needle-free vaccination. It is also the first vaccine to be authorized for teenagers. Zydus Cadila said that the vaccine, known as ZyCoV-D, generates the spike protein from the Coronavirus, which stimulates an immune response to treat the disease. The vaccine's effectiveness is estimated to be around 67 percent. According to the company, the vaccine is also effective against Coronavirus variations, including the highly infectious Delta form. Now India has a total of 6 Covid-19 vaccines including Zydus Cadila ZyCoV-D. A huge number of the population is still not vaccinated and out of that, a huge chunk is of adolescents. With this, all the children of the age group from 12 to 17 will get vaccinated.